Connect Biopharma (CNTB) Tops Q2 EPS by 189c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts CNTB Hot Sheet
Join SI Premium – FREE
Connect Biopharma (NASDAQ: CNTB) reported Q2 EPS of ($0.27), $1.89 better than the analyst estimate of ($2.16). Revenue for the quarter came in at $2.77 million versus the consensus estimate of $226.48 thousand.
For earnings history and earnings-related data on Connect Biopharma (CNTB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP SE (SAP) Beats Q3 EPS by EUR0.06; offers outlook
- Wyndham Hotels & Resorts, Inc. (WH) Tops Q3 EPS by 12c, Beats on Revenue; Offers FY26 EPS Guidance
- Brandywine Realty Trust (BDN) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
